Search

everythinglearnresearchcommunity

for

Search:↓

The CRH/CRH-R1 system might be involved in causing lichen planus.

Diabetes can cause a variety of skin disorders, some of which may signal more serious health issues.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

Effective treatments for severe alopecia areata are still lacking.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Effective symptom management in IBD improves quality of life and prevents complications.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Two siblings both had a rare case of alopecia areata at the same time.

The conclusion is that a systematic approach is key for treating symmetrical alopecia in dogs, but treatment may not always be necessary.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

Some horses lose hair without inflammation or itching due to various conditions, and while mainly a cosmetic issue, diagnosis requires examination and biopsies, and breeding is not advised if it's hereditary.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Norwegian puffin dogs have a unique type of hair loss that often doesn't get better on its own and responds well to ciclosporin treatment.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Oral vitamin D treatment can help some children with alopecia areata who have vitamin D deficiency.